EFEMP1 and central nervous system cancer: Notably, some of these conditions have also been found to involve increased fibulin-3 expression levels (CTS [104] and glioma [107]), so it is possible that this specific SNP in the enhancer region leads to pathological EFEMP1 overexpression.